Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

419
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
419
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

360
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
360
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

1.8K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.8K
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

196
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
196
Analgesia and Pain Management01:25

Analgesia and Pain Management

788
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
788
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

498
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
498

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

[Clinical pharmacological medication reviews].

Ugeskrift for laeger·2026
Same author

Ugeskrift for laeger·2026
Same author

Effect of vascular access strategy on long-term outcomes in patients with out-of-hospital cardiac arrest: a randomised clinical trial.

Resuscitation·2026
Same author

The impact of psychiatric comorbidity on weight loss after bariatric surgery a 2-year register-based follow-up cohort study.

Obesity research & clinical practice·2026
Same author

A prospective pharmacokinetic study of chlordiazepoxide in patients admitted to an intensive care unit or a high dependency unit after treatment of alcohol withdrawal symptoms.

Clinical toxicology (Philadelphia, Pa.)·2026
Same author

Reducing severe breathlessness with dronabinol in the group of patients with severe and very severe chronic obstructive pulmonary disease (BONG): a randomised, double-blinded, placebo-controlled, crossover study in an outpatient clinic in Denmark - a study protocol.

BMJ open·2026
Same journal

Ugeskrift for laeger·2026
Same journal

[Financial support scheme following a recognised occupational injury].

Ugeskrift for laeger·2026
Same journal

[Foreign body granulomas in the lungs after several years of parenteral nutrition].

Ugeskrift for laeger·2026
Same journal

[Vaginal aids for stress incontinence].

Ugeskrift for laeger·2026
Same journal

[Osteodystrophy in chronic liver disease].

Ugeskrift for laeger·2026
Same journal

[Tympanic membrane perforation].

Ugeskrift for laeger·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: Sep 9, 2025

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
10:13

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

Published on: November 8, 2024

2.4K

[Fentanyl] ¿Qué es el fentanilo?

Søren Viborg Vestergaard1,2, Anders Valentin Abildgaard Nielsen3, Malene Hollingdal4

  • 1Klinisk Farmakologi, Aarhus Universitetshospital.

Ugeskrift for laeger
|September 5, 2025
PubMed
Resumen
Este resumen es generado por máquina.

Fentanilo y sus derivados

Más Videos Relacionados

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

12.8K
Computer-based Multitaper Spectrogram Program for Electroencephalographic Data
04:13

Computer-based Multitaper Spectrogram Program for Electroencephalographic Data

Published on: November 13, 2019

12.3K

Videos de Experimentos Relacionados

Last Updated: Sep 9, 2025

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
10:13

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

Published on: November 8, 2024

2.4K
Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

12.8K
Computer-based Multitaper Spectrogram Program for Electroencephalographic Data
04:13

Computer-based Multitaper Spectrogram Program for Electroencephalographic Data

Published on: November 13, 2019

12.3K

Área de la Ciencia:

  • Anestesiología y farmacología

Sus antecedentes:

  • El fentanilo es un analgésico opioide eficaz para el dolor agudo.
  • Su eliminación lenta puede causar depresión respiratoria prolongada y sedación.
  • La distribución de las grasas afecta el perfil farmacocinético del fentanilo.

Objetivo del estudio:

  • Revisar la farmacocinética del fentanilo y los riesgos asociados.
  • Para resaltar las poblaciones de pacientes con mayor riesgo de eventos adversos.
  • Hacer hincapié en la necesidad de directrices clínicas actualizadas.

Principales métodos:

  • Revisión de la literatura sobre las propiedades y el uso clínico del fentanilo.
  • Análisis de los factores que influyen en la eliminación del fentanilo y los efectos secundarios.
  • Identificación de perfiles y escenarios de pacientes de alto riesgo.

Principales resultados:

  • El tejido graso actúa como un depósito, prolongando los efectos del fentanilo.
  • Se recomienda una dosificación ideal del peso corporal para mitigar los riesgos.
  • Los pacientes con sobrepeso, aquellos con enfermedad pulmonar o que toman sedantes al mismo tiempo están en alto riesgo.
  • Los eventos adversos retrasados y relacionados con el sueño son una preocupación significativa.

Conclusiones:

  • Son necesarias directrices clínicas para el seguimiento posterior a la administración de fentanilo.
  • La optimización de la dosificación de fentanilo en función del peso corporal ideal es crucial.
  • La conciencia de los efectos secundarios retrasados y relacionados con el sueño es vital para la seguridad del paciente.